台灣神隆股份有限公司 News Releases

Taiwan Biotech Company (1789) Reports Q4 2025 Financials: EPS at NT$0.17

Taiwan Biotech Company (TWSE: 1789) announced its fourth quarter 2025 financial results, reporting b… · 2025-12-01

ScinoPharm Taiwan (1789) Q1 2026 EPS: NT$0.02

ScinoPharm Taiwan announced its Q1 2026 financial results, with consolidated EPS of NT$0.02, operati… · 2026-03-01

Taiwan Biotech Company (1789) Reports Q4 2025 Financials: EPS at NT$0.17

Taiwan Biotech Company (TWSE: 1789) announced its fourth quarter 2025 financial results, reporting b… · 2025-12-01

ScinoPharm Taiwan (1789) Q1 2026 EPS: NT$0.02

ScinoPharm Taiwan announced its Q1 2026 financial results, with consolidated EPS of NT$0.02, operati… · 2026-03-01